Neuroone Medical Technologies (NMTC) Shares Outstanding (2010 - 2026)

Neuroone Medical Technologies' Shares Outstanding (Entity) history runs 15 years deep, the most recent figure standing at $4.3 million for Q1 2024.

• Quarterly Shares Outstanding (Entity) rose 53.43% year-over-year to $4.3 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $4.3 million (up 53.43% YoY) and the FY2023 annual result came in at $3.0 million, up 11.74% from the prior year.
• Shares Outstanding (Entity) was $4.3 million for Q1 2024 at Neuroone Medical Technologies, up from $4.1 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $4.3 million in Q1 2024 and bottomed at $779016.0 in Q1 2020.
• A 5-year average of $2.4 million and a median of $2.7 million in 2022 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) jumped 154.82% — and 2022, when it grew 0.31%.
• Neuroone Medical Technologies' Shares Outstanding (Entity) stood at $1.3 million in 2020, then surged by 110.32% to $2.7 million in 2021, then rose by 0.31% to $2.7 million in 2022, then jumped by 52.92% to $4.1 million in 2023, then gained by 4.35% to $4.3 million in 2024.
• Business Quant data shows NMTC's Shares Outstanding (Entity) at $4.3 million in Q1 2024, $4.1 million in Q4 2023, and $3.0 million in Q3 2023.